In addition to nerve growth factor (NGF), release and disease modification approaches to AD, the role of nanoparticles in the brain, in genes, and in cell screening therapy from polymerized implants, as a neuroprotector, was emphasized. This evidence concerns the gene NGF and Alzheimer disease.